MoneyWorks4Me

Cipla reports 15% rise in Q3 consolidated net profit

13 Feb 2015 Evaluate

Cipla has reported results for third quarter ended December 31, 2014.

The company has registered a rise of 14.64% in its net profit at Rs 298.95 crore for the quarter under review as compared to Rs 260.77 crore for the same quarter in the previous year. Total income of the company increased by 6.79% at Rs 2512.87 crore for Q3FY15 as compared Rs 2353.19 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit after minority interest and share of profit/(loss) of associate rose 15.31% to Rs 327.85 crore for the Q3 FY15, as compared to Rs 284.31 crore in Q3 FY14. The total income increased 6.24% to Rs 2806.12 crore in the quarter under review as compared to Rs 2641.22 crore in the corresponding quarter previous year.

Cipla Share Price

1423.15 -8.70 (-0.61%)
19-Aug-2026 12:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1892.70
Dr. Reddys Labs. 1177.90
Cipla 1423.15
Lupin 2204.20
Zydus Lifesciences 1113.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: